ArticleBiomedical optics express2026
Wavenumber-space wavefront sensorless adaptive-optics for optical coherence tomography.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Joint feature issue inBiomedical optics express · 2026Article
- Erratum: Wavenumber-space wavefront sensorless adaptive-optics for optical coherence tomography: publisher's note.Biomedical optics express · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
Abstract
Adaptive-optics optical coherence tomography (AO-OCT) allows the visualization of cellular-scale retinal structures; however, its adoption both at research and clinical levels has been restricted by hardware and software complexity. Based on the observation that aberrations other than defocus are depth-independent, we propose an approach for wavefront sensorless AO-OCT that utilizes the interferometric fringe modulation in wavenumber (
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.